Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Switching from natalizumab to fingolimod: an observational study

(2013) A. P. Sempere et al.   ACTA NEUROLOGICA SCANDINAVICA

Reduction of the washout time between natalizumab and fingolimod

(2013) Jérôme de Seze et al.   Multiple Sclerosis Journal

Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment

(2012) Joachim B. Havla   ARCHIVES OF NEUROLOGY

Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab

(2012) S. Rossi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

(2012) Joachim Havla et al.   JOURNAL OF NEUROLOGY

Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption

(2012) A Laroni et al.   Multiple Sclerosis Journal

Switching therapy from natalizumab to fingolimod in relapsing–remitting multiple sclerosis: clinical and magnetic resonance imaging findings

(2012) F Rinaldi et al.   Multiple Sclerosis Journal

A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation

(2012) Silvia Rossi et al.   Multiple Sclerosis Journal

Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases

(2012) Bahia Hakiki et al.   Multiple Sclerosis Journal

Lethal multiple sclerosis relapse after natalizumab withdrawal

(2012) V. Rigau et al.   NEUROLOGY

Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study

(2011) María José Magraner et al.   JOURNAL OF NEUROLOGY

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

(2011) A. Kerbrat et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse

(2011) C Papeix et al.   Multiple Sclerosis Journal

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

(2011) Kerstin Hellwig et al.   Multiple Sclerosis Journal

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

(2011) P. W. O'Connor et al.   NEUROLOGY

Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated

(2010) Joep Killestein et al.   ANNALS OF NEUROLOGY

Natalizumab dosage suspension: Are we helping or hurting?

(2010) Timothy W. West et al.   ANNALS OF NEUROLOGY

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy

(2010) Augusto Miravalle et al.   ARCHIVES OF NEUROLOGY

Observations during an elective interruption of natalizumab treatment: a post-marketing study

(2010) Giovanna Borriello et al.   Multiple Sclerosis Journal

GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study

(2009) A. D. Goodman et al.   NEUROLOGY

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

(2008) O. Stuve et al.   NEUROLOGY